News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Nanotherapy effective in mice with multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.05.22]
Researchers have designed a nanoparticle-based therapy that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow.
Pilot clinical trial finds injected immune cells safe in multiple myeloma patients
Source: Immune System / Vaccines News From Medical News Today [2015.05.21]
Thirteen of 22 patients experienced some reductions in cancerous white blood cellsThis image shows marrow-infiltrating lymphocytes in cell culture. Credit: Credit: Kimberly Noonan, Ph.D.
Shell-less chicken eggs for multiple myeloma research
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.05.06]
Innsbruck scientists grow miniature tumours on eggshell membranes. The EU project OPTATIO succeeded in developing an urgently needed drug screening system for bone marrow cancer.
Stem cell transplantation for multiple myeloma: New data did not change conclusion
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.05.02]
Update search still showed insufficient evidence base/ Conclusions possible on 6 of 9 subindicationsAn update search enlarged the pool of study data, but did not change the content of the...
Source: MedicineNet Multiple Myeloma Specialty [2015.04.30]
Title: Multiple Myeloma
Category: Symptoms and Signs
Created: 4/30/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM
Farydak Approved for Multiple Myeloma
Source: MedicineNet Multiple Myeloma Specialty [2015.02.25]
Title: Farydak Approved for Multiple Myeloma
Category: Health News
Created: 2/24/2015 12:00:00 AM
Last Editorial Review: 2/25/2015 12:00:00 AM
What to Expect in Hematologic Malignancies
Source: Medscape Hematology-Oncology Headlines [2015.05.22]
Dr Bruce Cheson previews the most important trials being presented at ASCO 2015 on Hodgkin's and non-Hodgkin's lymphoma, acute and chronic leukemia, and multiple myeloma.